SCHEMBL4172632

SCHEMBL4172632

COC(=O)CCCCCCCCC(=O)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.71
L3MBTL1 Q9Y468 2/20 0.71
LMNA P02545 2/20 0.71
MAPT P10636 2/20 0.71
HDAC8 Q9BY41 8/20 0.65
HDAC1 Q13547 8/20 0.65
HDAC3 O15379 3/20 0.65
HDAC2 Q92769 3/20 0.65
HDAC4 P56524 2/20 0.65
HDAC7 Q8WUI4 2/20 0.65
HDAC10 Q969S8 2/20 0.65
HDAC11 Q96DB2 2/20 0.65
HDAC6 Q9UBN7 2/20 0.65
HDAC9 Q9UKV0 2/20 0.65
HDAC5 Q9UQL6 2/20 0.65
NPC1 O15118 1/20 0.53
CASP3 P42574 1/20 0.53
RAB9A P51151 1/20 0.53
SENP8 Q96LD8 1/20 0.53
SENP7 Q9BQF6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6913209 1.00 TDP1 (0.71) TDP1L3MBTL1LMNAMAPTHDAC8
SCHEMBL6156819 1.00 TDP1 (0.71) TDP1L3MBTL1LMNAMAPTHDAC8
SCHEMBL29048469 1.00 TDP1 (0.71) TDP1L3MBTL1LMNAMAPTHDAC8
SCHEMBL6336402 0.98 TDP1 (0.68) TDP1L3MBTL1LMNAMAPTHDAC8
SCHEMBL941120 0.95 TDP1 (0.62) TDP1L3MBTL1LMNAMAPTHDAC8
SCHEMBL10986985 0.88 HDAC1 (0.63) TDP1L3MBTL1LMNAMAPTHDAC8
SCHEMBL135356 0.87 NR4A2 (0.61) TDP1L3MBTL1LMNAMAPTKMT2A
SCHEMBL13335151 0.87 L3MBTL1 (0.56) TDP1L3MBTL1LMNAMAPTHDAC8
SCHEMBL10651358 0.85 NPC1 (0.59) TDP1L3MBTL1LMNAMAPTHDAC8
SCHEMBL10648371 0.85 LTA4H (0.54) TDP1L3MBTL1LMNAMAPTHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227571-A1 Androgen Receptor Modulator Compounds and Methods LIGAND PHARMACEUTICALS INCORPORATED 2009-09-10 US disclosed
EP-0323050-B1 Photosensitive compound WAKO PURE CHEM IND LTD (JP) 1994-11-02 EP disclosed
US-5250669-A Thermostability, photoresists WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1993-10-05 US disclosed
EP-0323050-A2 Photosensitive compound WAKO PURE CHEMICAL INDUSTRIES LTD (JP) 1989-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227571-A1 Androgen Receptor Modulator Compounds and Methods AR, NR5A1, ESRRA TDP1 4164/4885L3MBTL1 4784/4885LMNA 3833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.